Cytomegalovirus infection and aplastic crisis in glucose-6-phosphate dehydrogenase deficiency

[Safety and efficacy of gonioscopy-assisted transluminal trabeculotomy (GATT) - A single-center retrospective study].

Journal francais d'ophtalmologie·2026

Management of glaucoma in high myopia: Guidelines from the French Glaucoma Society (SFG) and the French-speaking Retina Specialists' Club (CFSR).

Journal francais d'ophtalmologie·2026

[XEN Gel Stent: Long-term safety and efficacy in glaucoma surgery - a single-center retrospective study].

Journal francais d'ophtalmologie·2026

[Review of surgical techniques for XEN Gel Stent implantation in glaucoma surgery].

Journal francais d'ophtalmologie·2025

[OCT-angiography in glaucoma diagnosis - A multicenter case-control study].

Journal francais d'ophtalmologie·2025

["Projet doré": Screening for ocular pathologies in nursing home residents].

Journal francais d'ophtalmologie·2024

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Exertional Rhabdomyolysis With Moderate Creatine Kinase Elevation and Marked Transaminase Elevation but Preserved Synthetic Function: A Case Report.

The American journal of case reports·2026

The Changing Landscape of Metabolic and Bariatric Surgery: Aligning Access With the Clinical Obesity Framework.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2026

Diagnostic performance of FIB-6 for identifying FibroScan-defined advanced fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): a cross-sectional diagnostic accuracy study.

BMC gastroenterology·2026

Comparative Performance of Preoperative Diabetes-Remission Scores Following Metabolic Bariatric Surgery: A Retrospective Cohort Study in a Malaysian Population.

Obesity surgery·2026

Exhaled breath metabolomics: Clinical diagnostic applications, technological evolution and translational challenges.

Clinica chimica acta; international journal of clinical chemistry·2026

Depressive symptom profiles and risk of cardiometabolic disease incidence.

Journal of affective disorders·2026

Related Experiment Videos

Cytomegalovirus infection and aplastic crisis in glucose-6-phosphate dehydrogenase deficiency

Related Concept Videos

[Safety and efficacy of gonioscopy-assisted transluminal trabeculotomy (GATT) - A single-center retrospective study].

Management of glaucoma in high myopia: Guidelines from the French Glaucoma Society (SFG) and the French-speaking Retina Specialists' Club (CFSR).

[XEN Gel Stent: Long-term safety and efficacy in glaucoma surgery - a single-center retrospective study].

[Review of surgical techniques for XEN Gel Stent implantation in glaucoma surgery].

[OCT-angiography in glaucoma diagnosis - A multicenter case-control study].

["Projet doré": Screening for ocular pathologies in nursing home residents].

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Exertional Rhabdomyolysis With Moderate Creatine Kinase Elevation and Marked Transaminase Elevation but Preserved Synthetic Function: A Case Report.

The Changing Landscape of Metabolic and Bariatric Surgery: Aligning Access With the Clinical Obesity Framework.

Diagnostic performance of FIB-6 for identifying FibroScan-defined advanced fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): a cross-sectional diagnostic accuracy study.

Comparative Performance of Preoperative Diabetes-Remission Scores Following Metabolic Bariatric Surgery: A Retrospective Cohort Study in a Malaysian Population.

Exhaled breath metabolomics: Clinical diagnostic applications, technological evolution and translational challenges.

Depressive symptom profiles and risk of cardiometabolic disease incidence.

Related Experiment Videos

Cytomegalovirus infection and aplastic crisis in glucose-6-phosphate dehydrogenase deficiency

Related Concept Videos

Related Articles